Buy Exelixis Stock | EXEL Stock Price & Latest News | Public
EXEL

Exelixis

$0.00 (0.00%)Today

    About EXEL

    Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.22
    0.15
    0.07
    0
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    $0.05

    Actual EPS
    Q3 2020

    Stats

    Market Cap$8,32B
    Volume146,48k
    Price-to-Earnings Ratio30.23
    Dividend Rate
    Dividend Yield
    1 Year High$27.80
    1 Year Low$13.67
    Open$27.13
    High$27.13
    Low$26.39

    Buy any stock with any amount of money.

    Download the App
    Download the app